Compare MTRX & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTRX | SGHT |
|---|---|---|
| Founded | 1984 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.0M | 309.6M |
| IPO Year | 1995 | 2021 |
| Metric | MTRX | SGHT |
|---|---|---|
| Price | $10.84 | $8.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $17.00 | $9.08 |
| AVG Volume (30 Days) | 188.2K | ★ 263.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $769,286,000.00 | $77,363,000.00 |
| Revenue This Year | $19.75 | $11.67 |
| Revenue Next Year | $7.96 | $10.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.64 | N/A |
| 52 Week Low | $9.88 | $3.19 |
| 52 Week High | $15.97 | $9.24 |
| Indicator | MTRX | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 73.02 |
| Support Level | $10.79 | $8.00 |
| Resistance Level | $12.48 | $8.80 |
| Average True Range (ATR) | 0.30 | 0.37 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 17.75 | 59.84 |
Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.